Department of Cardiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Sci Rep. 2023 Mar 8;13(1):3892. doi: 10.1038/s41598-023-31163-0.
Patients with severe asymptomatic primary mitral regurgitation (MR) can be safely managed with an active surveillance strategy. Left atrial (LA) size is affected by MR severity, left ventricular function and is also associated with the risk of atrial fibrillation and may be an integrative parameter for risk stratification. The present study sought to determine the predictive value of LA size in a large series of asymptomatic patients with severe MR. 280 consecutive patients (88 female, median age 58 years) with severe primary MR and no guideline-based indications for surgery were included in a follow-up program until criteria for mitral surgery were reached. Event-free survival was determined and potential predictors of outcome were assessed. Survival free of any indication for surgery was 78% at 2 years, 52% at 6 years, 35% at 10 years and 19% at 15 years, respectively. Left atrial (LA) diameter was the strongest independent echocardiographic predictor of event-free survival with incremental predictive value for the thresholds of 50, 60 and 70 mm, respectively. In a multivariable analysis that encompassed age at baseline, previous history of atrial fibrillation, left ventricular end systolic diameter), LA diameter, sPAP > 50 mmHg and year of inclusion, LA diameter was the strongest independent echocardiographic predictor of event-free survival (adjusted HR = 1.039, p < 0.001). LA size is a simple and reproducible predictor of outcome in asymptomatic severe primary MR. In particular, it may help to identify patients who may benefit from early elective valve surgery in heart valve centers of excellence.
患有严重无症状原发性二尖瓣反流(MR)的患者可以通过积极监测策略安全地进行管理。左心房(LA)的大小受 MR 严重程度、左心室功能的影响,也与心房颤动的风险相关,并且可能是风险分层的综合参数。本研究旨在确定 LA 大小在一系列患有严重原发性 MR 且无症状的患者中的预测价值。
280 例连续患者(88 例女性,中位年龄 58 岁)患有严重原发性 MR,且无手术适应证的指南,纳入随访计划,直至达到二尖瓣手术标准。确定无任何手术适应证的无事件生存率,并评估潜在的预后预测因素。
无任何手术适应证的生存分别为 2 年时 78%,6 年时 52%,10 年时 35%,15 年时 19%。LA 直径是无事件生存率的最强独立超声心动图预测因素,分别具有 50、60 和 70mm 的递增预测价值。
在纳入年龄、先前心房颤动史、左心室收缩末期直径、LA 直径、sPAP>50mmHg 和纳入年份的多变量分析中,LA 直径是无事件生存率的最强独立超声心动图预测因素(调整后的 HR=1.039,p<0.001)。
LA 大小是无症状严重原发性 MR 患者预后的简单且可重复的预测因素。特别是,它可能有助于识别在心脏瓣膜卓越中心可能受益于早期选择性瓣膜手术的患者。